About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Prkacatm1Gsm
targeted mutation 1, G Stanley McKnight
MGI:2181021
Summary 7 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Prkacatm1Gsm/Prkacatm1Gsm involves: 129X1/SvJ * C57BL/6 MGI:2663265
ht2
Prkacatm1Gsm/Prkaca+ involves: 129X1/SvJ * C57BL/6 MGI:4868207
cx3
Prkacatm1Gsm/Prkaca+
Prkar1atm1.1Lsk/Prkar1a+
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 MGI:4868214
cx4
Prkacatm1Gsm/Prkacatm1Gsm
Prkar1atm1Gsm/Prkar1atm1Gsm
involves: 129X1/SvJ * C57BL/6 MGI:3625132
cx5
Prkacatm1Gsm/Prkaca+
Prkacbtm1Gsm/Prkacbtm1Gsm
involves: 129X1/SvJ * C57BL/6 MGI:3628809
cx6
Prkacatm1Gsm/Prkacatm1Gsm
Prkacbtm1Gsm/Prkacb+
involves: 129X1/SvJ * C57BL/6 MGI:3628811
cx7
Prkacatm1Gsm/Prkacatm1Gsm
Prkacbtm1Gsm/Prkacbtm1Gsm
involves: 129X1/SvJ * C57BL/6 MGI:3628813


Genotype
MGI:2663265
hm1
Allelic
Composition
Prkacatm1Gsm/Prkacatm1Gsm
Genetic
Background
involves: 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkacatm1Gsm mutation (1 available); any Prkaca mutation (22 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• influenced by genetic background, with decreased survival associated with increased C57BL/6 contribution
• some mice surviving past weaning

growth/size/body
• 35% reduction in weight at 3 months of age relative to wild-type littermates
• beginning at 2 weeks of age (J:77110)
• normal serum levels of growth hormone (GH) though mice were partially GH resistant (J:77110)

homeostasis/metabolism
• reduction in the levels of major urinary proteins

renal/urinary system
• reduction in the levels of major urinary proteins

reproductive system
N
• full spectrum of male gametes observed indicating normal spermatogenesis
• normal testicular weight
• normal sperm count
• reduced forward velocity

cellular
• reduced forward velocity




Genotype
MGI:4868207
ht2
Allelic
Composition
Prkacatm1Gsm/Prkaca+
Genetic
Background
involves: 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkacatm1Gsm mutation (1 available); any Prkaca mutation (22 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
skeleton
• trabecular bone is decreased
• mutants exhibit overall gain in bone formation derived from primarily cortical bone




Genotype
MGI:4868214
cx3
Allelic
Composition
Prkacatm1Gsm/Prkaca+
Prkar1atm1.1Lsk/Prkar1a+
Genetic
Background
involves: 129S1/Sv * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkacatm1Gsm mutation (1 available); any Prkaca mutation (22 available)
Prkar1atm1.1Lsk mutation (0 available); any Prkar1a mutation (19 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
N
• mutants do not develop schwannomas or thyroid tumors
• mutants develop a greater number of osseous lesions and develop them earlier than single Prkar1a heterozygotes (J:160299)
• 90% of mutants exhibit bone lesions in the tail by 6 months and 100% by 9 months of age (J:160299)
• osseous lesions are seen starting around 3 months of age and vary from rare chondromas in the long bones and ubiquitous osteochondrodysplasia of vertebral bodies to occasional sarcoma (J:160299)
• 13% of mutants develop osteochondromyoxoma (J:160299)
• cells from the bone lesions originate from an area proximal to the growth plate (J:160299)
• cartilaginous metaplasia, chondromas, and osteochondrodysplasia are seen in marrow cavities of up to 1/3 of the long bones and most of the vertebral bodies (J:160299)
• lesions are hypercellular and contain more irregular cartilage or bone islands; proliferating cells are committed osteogenic but are not able to mature into osteoblasts (J:160299)
• mutants develop bone tumors with histological resemblance to those seen in humans with neonatal-onset multisystem inflammatory disease, with lesions derived from osteoblast progenitor cells (J:166728)
• rare development of metastatic osteochondrosarcomas
• rare chondromas in the long bones

skeleton
• mutants develop a greater number of osseous lesions and develop them earlier than single Prkar1a heterozygotes (J:160299)
• 90% of mutants exhibit bone lesions in the tail by 6 months and 100% by 9 months of age (J:160299)
• osseous lesions are seen starting around 3 months of age and vary from rare chondromas in the long bones and ubiquitous osteochondrodysplasia of vertebral bodies to occasional sarcoma (J:160299)
• 13% of mutants develop osteochondromyoxoma (J:160299)
• cells from the bone lesions originate from an area proximal to the growth plate (J:160299)
• cartilaginous metaplasia, chondromas, and osteochondrodysplasia are seen in marrow cavities of up to 1/3 of the long bones and most of the vertebral bodies (J:160299)
• lesions are hypercellular and contain more irregular cartilage or bone islands; proliferating cells are committed osteogenic but are not able to mature into osteoblasts (J:160299)
• mutants develop bone tumors with histological resemblance to those seen in humans with neonatal-onset multisystem inflammatory disease, with lesions derived from osteoblast progenitor cells (J:166728)
• rare development of metastatic osteochondrosarcomas
• rare chondromas in the long bones
• overall bone mineralization density is lower than in wild-type mice
• in affected bones, normal cortical bone is replaced by mineralized material
• periosteum of affected bones is abnormal, with occasional cells from lesions crossing the periosteum into the extraosseous space and Sharpey fibers, characteristic of fibrous dysplasia, are observed
• although the bone marrow is expanded by active osteoclastic activity, these cells are not able to mature into osteoblasts and mineralize the matrix resulting in undermineralization
• bones exhibit a lag between bone matrix formation and mineralization and abnormal coordination of these processes with bone resorption

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
CINCA Syndrome DOID:0090029 OMIM:607115
J:166728




Genotype
MGI:3625132
cx4
Allelic
Composition
Prkacatm1Gsm/Prkacatm1Gsm
Prkar1atm1Gsm/Prkar1atm1Gsm
Genetic
Background
involves: 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkacatm1Gsm mutation (1 available); any Prkaca mutation (22 available)
Prkar1atm1Gsm mutation (1 available); any Prkar1a mutation (19 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• E10.5 embryos exhibit an expanded fluid-filled pericardial cavity, even though exhibit rescue of the other phenotypes seen in Prkar1a null mice (develop a heart tube, undergo embryo turning, etc)

homeostasis/metabolism
• E10.5 embryos exhibit an expanded fluid-filled pericardial cavity, even though exhibit rescue of the other phenotypes seen in Prkar1a null mice (develop a heart tube, undergo embryo turning, etc)




Genotype
MGI:3628809
cx5
Allelic
Composition
Prkacatm1Gsm/Prkaca+
Prkacbtm1Gsm/Prkacbtm1Gsm
Genetic
Background
involves: 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkacatm1Gsm mutation (1 available); any Prkaca mutation (22 available)
Prkacbtm1Gsm mutation (0 available); any Prkacb mutation (29 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Neural tube defects leading to spina bifida in Prkacatm1Gsm/Prkaca+ Prkacbtm1Gsm/Prkacbtm1Gsm and Prkacatm1Gsm/Prkacatm1Gsm Prkacbtm1Gsm/Prkacb+ mice

mortality/aging
• if mutant pups are kept with their parents, they are rejected and left out of the litter and die, probably from starvation

nervous system
• increase in apoptotic cells in the dorsal and lateral regions of the neural tube
• 100% show spinal neural tube defects
• E9.5-10.5 embryos exhibit a closed neural tube with an expanded alar plate and enlarged lumen in the thoracic and lumbar regions and an expanded neuroepithelium
• E10.5 or older embryos show a drastic increase in the expansion of the neural canal (enlarged lumen) and a neuroepithelium with a higher cell density
• E9.5-E10.5 embryos exhibit an expanded neuroepithelium with a higher cell density
• at the thoracic and lumbar regions
• altered neuronal identity in the neural tube posterior to the forelimb buds leading to a ventralized neural tube (appearance of ventral neuronal progenitors in the dorsal neural tube and loss of dorsal cell types)
• dorsal root ganglia form in E10.5 embryos but regress at E12.5
• significant increase in cell death in the dorsal root ganglia adjacent to the affected neural tube
• dorsal root ganglia are formed in E10.5 embryos but are disorganized

skeleton
• spinal column defects are located in the thoracic and lumbar regions
• ventral curvature of the spine at the defective region
• vertebral arches fail to fuse at the dorsal midline between forelimbs and hindlimbs

embryo
• 100% show spinal neural tube defects
• E9.5-10.5 embryos exhibit a closed neural tube with an expanded alar plate and enlarged lumen in the thoracic and lumbar regions and an expanded neuroepithelium
• E10.5 or older embryos show a drastic increase in the expansion of the neural canal (enlarged lumen) and a neuroepithelium with a higher cell density
• E9.5-E10.5 embryos exhibit an expanded neuroepithelium with a higher cell density
• at the thoracic and lumbar regions

cellular
• increase in apoptotic cells in the dorsal and lateral regions of the neural tube




Genotype
MGI:3628811
cx6
Allelic
Composition
Prkacatm1Gsm/Prkacatm1Gsm
Prkacbtm1Gsm/Prkacb+
Genetic
Background
involves: 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkacatm1Gsm mutation (1 available); any Prkaca mutation (22 available)
Prkacbtm1Gsm mutation (0 available); any Prkacb mutation (29 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Neural tube defects leading to spina bifida in Prkacatm1Gsm/Prkaca+ Prkacbtm1Gsm/Prkacbtm1Gsm and Prkacatm1Gsm/Prkacatm1Gsm Prkacbtm1Gsm/Prkacb+ mice

mortality/aging

nervous system
• 75% show spinal neural tube defects
• 25% show spinal neural tube defects and exencephaly
• E9.5-10.5 embryos exhibit a closed neural tube with an expanded alar plate and enlarged lumen in the thoracic and lumbar regions and an expanded neuroepithelium
• E10.5 or older embryos show a drastic increase in the expansion of the neural canal (enlarged lumen) and a neuroepithelium with a higher cell density
• exhibit an increase in apoptotic cells in the dorsal and lateral regions of the neural tube
• E9.5-E10.5 embryos exhibit an expanded neuroepithelium with a higher cell density
• at the thoracic and lumbar regions
• 25% show spinal neural tube defects and exencephaly; exencephaly alone is not observed
• altered neuronal identity in the neural tube posterior to the forelimb buds leading to a ventralized neural tube (appearance of ventral neuronal progenitors in the dorsal neural tube and loss of dorsal cell types)
• dorsal root ganglia form in E10.5 embryos but regress at E12.5
• significant increase in cell death in the dorsal root ganglia adjacent to the affected neural tube
• dorsal root ganglia are formed in E10.5 embryos but are disorganized

skeleton
• spinal column defects are located in the thoracic and lumbar regions
• ventral curvature of the spine at the defective region
• vertebral arches fail to fuse at the dorsal midline between forelimbs and hindlimbs

embryo
• 75% show spinal neural tube defects
• 25% show spinal neural tube defects and exencephaly
• E9.5-10.5 embryos exhibit a closed neural tube with an expanded alar plate and enlarged lumen in the thoracic and lumbar regions and an expanded neuroepithelium
• E10.5 or older embryos show a drastic increase in the expansion of the neural canal (enlarged lumen) and a neuroepithelium with a higher cell density
• exhibit an increase in apoptotic cells in the dorsal and lateral regions of the neural tube
• E9.5-E10.5 embryos exhibit an expanded neuroepithelium with a higher cell density
• at the thoracic and lumbar regions




Genotype
MGI:3628813
cx7
Allelic
Composition
Prkacatm1Gsm/Prkacatm1Gsm
Prkacbtm1Gsm/Prkacbtm1Gsm
Genetic
Background
involves: 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Prkacatm1Gsm mutation (1 available); any Prkaca mutation (22 available)
Prkacbtm1Gsm mutation (0 available); any Prkacb mutation (29 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• all double mutants found at E8.5 to E10.5 are in various stages of resorption, indicating early embryonic lethality





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/07/2024
MGI 6.23
The Jackson Laboratory